vs

Side-by-side financial comparison of Commercial Bancgroup, Inc. (CBK) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Commercial Bancgroup, Inc. is the larger business by last-quarter revenue ($23.1M vs $17.3M, roughly 1.3× Sol-Gel Technologies Ltd.). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs 41.3%, a 25.9% gap on every dollar of revenue.

Commercial Bancgroup, Inc. operates as a U.S. regional bank holding company that provides a full suite of retail and commercial banking products and services to individual consumers, small and medium-sized businesses, and local institutional clients. Its core offerings include deposit accounts, lending solutions, wealth management, and tailored financial advisory services for regional markets.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

CBK vs SLGL — Head-to-Head

Bigger by revenue
CBK
CBK
1.3× larger
CBK
$23.1M
$17.3M
SLGL
Higher net margin
SLGL
SLGL
25.9% more per $
SLGL
67.3%
41.3%
CBK

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
CBK
CBK
SLGL
SLGL
Revenue
$23.1M
$17.3M
Net Profit
$9.5M
$11.6M
Gross Margin
Operating Margin
65.1%
Net Margin
41.3%
67.3%
Revenue YoY
217.7%
Net Profit YoY
9.7%
487.6%
EPS (diluted)
$0.69
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBK
CBK
SLGL
SLGL
Q1 26
$23.1M
Q4 25
$23.5M
Q3 25
$22.8M
Q2 25
$17.3M
Q2 24
$5.4M
Q2 23
$594.0K
Q2 22
$3.5M
Net Profit
CBK
CBK
SLGL
SLGL
Q1 26
$9.5M
Q4 25
$9.9M
Q3 25
$9.5M
Q2 25
$11.6M
Q2 24
$2.0M
Q2 23
$-6.0M
Q2 22
$-134.0K
Operating Margin
CBK
CBK
SLGL
SLGL
Q1 26
Q4 25
Q3 25
53.8%
Q2 25
65.1%
Q2 24
29.9%
Q2 23
-1098.8%
Q2 22
-13.2%
Net Margin
CBK
CBK
SLGL
SLGL
Q1 26
41.3%
Q4 25
42.2%
Q3 25
41.4%
Q2 25
67.3%
Q2 24
36.4%
Q2 23
-1005.1%
Q2 22
-3.8%
EPS (diluted)
CBK
CBK
SLGL
SLGL
Q1 26
$0.69
Q4 25
$0.72
Q3 25
$0.77
Q2 25
$4.17
Q2 24
$0.71
Q2 23
$-0.22
Q2 22
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBK
CBK
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$24.3M
Total DebtLower is stronger
$118.2M
Stockholders' EquityBook value
$31.9M
Total Assets
$2.3B
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBK
CBK
SLGL
SLGL
Q1 26
Q4 25
Q3 25
$154.8M
Q2 25
$24.3M
Q2 24
$26.5M
Q2 23
$33.5M
Q2 22
$15.6M
Total Debt
CBK
CBK
SLGL
SLGL
Q1 26
$118.2M
Q4 25
$166.8M
Q3 25
$100.1M
Q2 25
Q2 24
Q2 23
Q2 22
Stockholders' Equity
CBK
CBK
SLGL
SLGL
Q1 26
Q4 25
Q3 25
$245.2M
Q2 25
$31.9M
Q2 24
$34.9M
Q2 23
$48.3M
Q2 22
$50.4M
Total Assets
CBK
CBK
SLGL
SLGL
Q1 26
$2.3B
Q4 25
$2.3B
Q3 25
$2.2B
Q2 25
$39.3M
Q2 24
$42.0M
Q2 23
$55.1M
Q2 22
$55.0M
Debt / Equity
CBK
CBK
SLGL
SLGL
Q1 26
Q4 25
Q3 25
0.41×
Q2 25
Q2 24
Q2 23
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBK
CBK

Net Interest Income$20.5M89%
Noninterest Income$2.6M11%

SLGL
SLGL

Segment breakdown not available.

Related Comparisons